Nanomedicines for the Delivery of Biologics

• Egile Nagusiak: John Wahlich (Egilea), Arpan Desai (Egilea), Francesca Greco (Egilea), Kathryn Hill (Egilea), Arwyn T. Jones (Egilea), Randall J. Mrsny (Egilea), Gianfranco Pasut (Egilea), Yvonne Perrie (Egilea), F. Philipp Seib (Egilea), Leonard W. Seymour (Egilea), Ijeoma F. Uchegbu (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2019-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

A special symposium of the Academy of Pharmaceutical Sciences Nanomedicines Focus Group reviewed the current status of the use of nanomedicines for the delivery of biologics drugs. This meeting was particularly timely with the recent approval of the first siRNA-containing product Onpattro™...